Archives: Speakers

Dr. Antonella Santuccione Chadha is a world-renowned medical doctor with deep expertise in neuroscience and psychiatry, combined with a proven track record in organizational leadership, research, and clinical development. She is the founder and pro bono CEO of the Women’s Brain Foundation, a non-profit organization dedicated to applying precision medicine to understand the impact of sex and gender on mental and brain health.

In addition to her role at the Women’s Brain Foundation, Dr. Chadha serves as Vice-President and board member of Euresearch, the Swiss agency supporting research and innovation across Europe. She is also an advisor to Innosuisse, where she supports the growth of Swiss SMEs in the innovation space.

Dr. Chadha’s career spans academic institutions, leading pharmaceutical companies such as Roche and Biogen, the Swiss regulatory agency for therapeutic products, and international policy organizations. She previously served as Chief Medical Officer and ad-interim CEO of Altoida, a digital health company pioneering AI-driven diagnostics in precision neurology. Across all her roles, she has led large teams in corporate, academic, and clinical environments.

Her work has earned widespread recognition. She has been named among the Top 100 Women in Business in Switzerland since 2018 and was honored as Woman of the Year in Switzerland in 2019. Dr. Chadha is also a recipient of the World Sustainability Award for advancing precision medicine, and the “Premio Medicina Italia” for her leadership during the pandemic. In 2022, she received the Veuve Clicquot Bold Woman Award in Switzerland. Most recently, in 2024, she was honored with the “Women Empowering Award” and  recognized for her contributions to Swiss reforms with the prestigious “Katherinenturm” Project. In 2025 she was listed among the Women leaders to watch.

Beverly is a pediatric pharmacist by training and has spent over 20 years working in biotechnology, holding diverse Medical Affairs roles across Europe, the United States, Asia Pacific and Emerging Markets. Her mission is to bridge the gap between medical innovation and patient accessibility, driven by a passion for developing therapies that truly resonate with patient needs and delivering outcomes that are meaningful to them.

Witnessing the significant access challenges faced by innovative medicines in reaching people in need prompted her to pivot into patient advocacy. She is now dedicated to addressing these barriers across the drug development lifecycle, collaborating with patients and those who care for them, physicians, access decision-makers and industry stakeholders to ensure that transformative therapies that are developed can reach those who need them most.

Anja is a Swiss qualified pharmacist with a Ph. D. in medicinal chemistry from ETH Zurich.

She started her career as a manager research and development at Fumapharm AG, a small Swiss Biotech company, where she coordinated CMC activities and pre-clinical research studies for an oral MS drug in late-stage development. Her role included management of multiple academic research collaborations as well as external suppliers.

Anja moved to Biogen after acquisition of Fumapharm, where she held various roles with increasing responsibility in CMC development and external manufacturing. She has been responsible for clinical and commercial supply of various products and supported multiple product launches across different modalities and product stages. In her last role at Biogen, she was heading the external manufacturing biologics technology platform and was leading a team of relationship managers for strategic CDMO accounts.

Most recently, Anja has worked at different start-up companies as head of CMC, responsible for all CMC and supply related aspects for pre-clinical oncology programs including antibody-drug conjugates, small molecules and gene therapy products. Setting up an external supplier network and contract laboratories, as well as managing relationships with alliance partners has been a key aspect of her work.

I have more than 15 years in a Leadership role in clinical operations and compliance combined with a strong educational background in pharmacy and specialization in clinical pharmacology. Currently I have a Senior Management role in compliance and risk management function. I have an excellent performance record and am motivated by leadership roles with a strong commercial impact.